Incyte
INCY
#1021
Rank
C$33.29 B
Marketcap
C$164.27
Share price
-1.57%
Change (1 day)
35.60%
Change (1 year)

Number of shares outstanding for Incyte (INCY)

Number of shares outstanding as of October 2026 : 200,378,000

According to Incyte's latest financial reports and stock price the company's current number of shares outstanding is 200,378,000. At the end of 2026 the company had 200,378,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Incyte from 2000 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.20 B1.49%
20250.19 B2.22%
20240.19 B-13.86%
20230.22 B0.72%
20220.22 B0.74%
20210.22 B0.8%
20200.21 B1.61%
20190.21 B1.29%
20180.21 B0.89%
20170.21 B11.94%
20160.18 B1.25%
20150.18 B9.62%
20140.16 B4.95%
20130.16 B22.93%
20120.13 B4.32%
20110.12 B3.33%
20100.12 B24.64%
200998.03 M6.11%
200892.38 M9.7%
200784.21 M0.43%
200683.85 M0.53%
200583.41 M13.76%
200473.32 M1.58%
200372.18 M6.56%
200267.74 M2.06%
200166.37 M3.6%
200064.06 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Novartis
NVS
1,905,000,000 850.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
5,699,000,000 2,744.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
891,500,000 344.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
540,000,000 169.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
20,063,000-89.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
670,696,000 234.72%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
131,566,000-34.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
34,618,000-82.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
248,067,253 23.80%๐Ÿ‡บ๐Ÿ‡ธ USA